These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2399692)

  • 81. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood cell destruction.
    Biondi CS; Cotorruelo CM; Ensinck A; Racca LL; Racca AL
    Clin Lab; 2004; 50(5-6):265-70. PubMed ID: 15209434
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vitro reactions of anti-Rh antibodies depending on the pattern of IgG subclasses.
    Górska B; Frankowska K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1101-3. PubMed ID: 107910
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.
    Everly MJ; Rebellato LM; Haisch CE; Briley KP; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Maldonado AQ; Harland RC; Terasaki PI
    Transplantation; 2014 Mar; 97(5):494-501. PubMed ID: 24487396
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effect of naturally occurring Rh antibodies on the survival of serologically incompatible red cells.
    Contreras M; de Silva M; Teesdale P; Mollison PL
    Br J Haematol; 1987 Apr; 65(4):475-8. PubMed ID: 3107611
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Haemolytic disease of the newborn due to anti-Mt a .
    Field TE; Wilson TE; Dawes BJ; Giles CM
    Vox Sang; 1972; 22(5):432-7. PubMed ID: 5032416
    [No Abstract]   [Full Text] [Related]  

  • 86. Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells.
    Boligan KF; Sandhu G; Branch DR
    Curr Protoc; 2022 Aug; 2(8):e504. PubMed ID: 35926124
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assays to predict the clinical significance of blood group antibodies.
    Zupańska B
    Curr Opin Hematol; 1998 Nov; 5(6):412-6. PubMed ID: 9814648
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detection of IgG anti-Lewis (a) antibodies in cord sera by kinetic Elisa.
    Spitalnik S; Cowles J; Cox MT; Blumberg N
    Vox Sang; 1985; 48(4):235-8. PubMed ID: 3984308
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Yta isoimmunization in pregnancy. A case report.
    Sacks DA; Johnson CS
    J Reprod Med; 1983 Jun; 28(6):407-9. PubMed ID: 6887148
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
    Larson PJ; Thorp JM; Miller RC; Hoffman M
    Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra.
    Yuan S; Armour R; Reid A; Abdel-Rahman KF; Rumsey DM; Phillips M; Nester T
    Immunohematology; 2005; 21(3):97-101. PubMed ID: 16178666
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG.
    Engelfriet CP; Overbeeke MA; Dooren MC; Ouwehand WH; von dem Borne AE
    Transfusion; 1994 Jul; 34(7):617-26. PubMed ID: 8053042
    [No Abstract]   [Full Text] [Related]  

  • 94. A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
    Hadley A; Wilkes A; Poole J; Arndt P; Garratty G
    Transfus Med; 1999 Dec; 9(4):337-42. PubMed ID: 10583888
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A quantitative antiglobulin test for IgG for use in blood transfusion serology.
    Merry AH; Thomson EE; Rawlinson VI; Stratton F
    Clin Lab Haematol; 1982; 4(4):393-402. PubMed ID: 7166025
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A comparison of results from antihuman globulin-graded reactions with the monocyte monolayer assay.
    Bowman K; Peña Marquez LA; Hawthorne L; Billingsley K; Kelham S; Liang S; Kalvelage M
    Immunohematology; 2023 Jun; 39(2):77-81. PubMed ID: 37405849
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The immune destruction of red cells.
    Engelfriet CP
    Transfus Med; 1992 Mar; 2(1):1-6. PubMed ID: 1308459
    [No Abstract]   [Full Text] [Related]  

  • 98. At(a-) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti-Ata.
    Sweeney JD; Holme S; McCall L; Huett D; Storry J; Reid M
    Transfusion; 1995 Jan; 35(1):63-7. PubMed ID: 7998074
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Potentially clinically significant anti-Di
    Branch DR; Holton MB; Ison T; Cote J; Dube C; Lau W
    Transfusion; 2021 Jan; 61(1):331-332. PubMed ID: 33616959
    [No Abstract]   [Full Text] [Related]  

  • 100. An IgG anti-I(T) detected in a Caucasian American.
    Garratty G; Haffleigh B; Dalziel J; Petz LD
    Transfusion; 1972; 12(5):325-9. PubMed ID: 19013860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.